coinmouse1
About
May early switch to rituximab-bendamustine within a affected person along with follicular non-Hodgkin lymphoma moving on during R-CHOP be considered frontline treatment?: An incident record.
May early switch to rituximab-bendamustine within a affected person along with follicular non-Hodgkin lymphoma moving on during R-CHOP be considered frontline treatment?: An incident record.